Delivery Order SPE2DB20D3303-SPE2DB25FA0WR
Award Date
6/30/25
Potential Completion Date
7/1/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a ceiling value of $1,022.80 and a completion date of July 3, 2025. It is a firm-fixed-price contract and is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, to support federal healthcare requirements. The contract has a ceiling value of $2,073.72 and a performance period through June 23, 2025. It is a firm fixed price contract, with no set-aside designation, indicating open...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,866.28 and is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes treatment medication. The contract is a firm fixed-price agreement with a performance period through June 10, 2025. There is no set-aside designation, indicating the contract was competitively awarded. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,160.08. The contract is a firm fixed price, non-set-aside delivery order that has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a ceiling value of $2,056.73 and a completion date of June 27, 2025. The contract type is Firm Fixed Price. This delivery order is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price of $1,848.98 and a completion date of July 3, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes treatment medication, with a ceiling value of $1,022.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,122.53 and a period of performance through May 14, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a ceiling value of $1,861.00 and a period of performance through June 30, 2025. The contract is a firm fixed price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,150.65. The contract is not set aside and is a firm fixed price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...